Fifty410 Monthly vs Prepaid Plans: 2026 Pricing and Plans Compared

Last reviewed: September 16, 2026 Last updated: September 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fifty410's prepaid tirzepatide plans deliver the lowest per-month rate if you commit to a three-month supply upfront: starter tier runs $399 for three months ($133 per month, our calculation), mid-dose $499 ($166/month), and high-dose $549 ($183/month). The monthly semaglutide plan bills $199 each month with no upfront commitment, totaling $2,388 over 12 months. Whether the prepaid discount justifies locking in three months of tirzepatide depends on your confidence in dose stability and your willingness to pay the full quarter in one transaction. We lay out the 12-month arithmetic, compare like-for-like options against PlexusDx multi-month pricing, and show when each model makes sense.

At-a-glance: Fifty410 billing models

All Fifty410 prices verified September 4, 2026 at www.fifty410.com/pricing. Per-month equivalents for tirzepatide are our calculation; actual billing is quarterly. 12-month totals assume four prepaid cycles per year.

Normalized 12-month cost breakdown

Fifty410 splits its catalog by compound and billing model. Semaglutide runs month-to-month at $199; tirzepatide ships as a three-month supply paid upfront, with three tiers keyed to dose level. To compare apples-to-apples, we calculate the effective monthly rate and project 12-month spend for each path.

Fifty410 semaglutide: straightforward monthly billing

The semaglutide injection plan charges $199 every month for a four-week supply. No membership fee, no contract. Over 12 months you pay $199 × 12 = $2,388. The rate never changes, and you can pause or cancel without penalty.

Fifty410 tirzepatide: prepaid quarterly cycles

All three tirzepatide tiers require payment for three months upfront; the full supply ships immediately. You repeat the cycle four times across the year:

• Starter tier: $399 per quarter → $399 × 4 = $1,596 annually → $133/month effective rate (our calculation).
• Mid-dose tier: $499 per quarter → $499 × 4 = $1,996 annually → $166/month effective rate (our calculation).
• High-dose tier: $549 per quarter → $549 × 4 = $2,196 annually → $183/month effective rate (our calculation).

Each prepaid rate is lower than the $199 monthly semaglutide charge, but the trade-off is upfront capital and dose lock-in: if your clinician adjusts dose mid-quarter, you have already paid for the original tier.

PlexusDx semaglutide: month-to-month and commitment pricing

PlexusDx semaglutide injection offers three billing lengths at a single dose-agnostic rate (prices verified internal records, September 2026):

• Month-to-month: $189/month → $2,268 over 12 months.
• 3-month commitment: $169/month → $2,028 over 12 months.
• 6-month commitment: $149/month → $1,788 over 12 months.

The month-to-month rate undercuts Fifty410 semaglutide by $10/month ($120/year). The 6-month commitment saves an additional $480 compared to PlexusDx month-to-month.

PlexusDx tirzepatide: month-to-month and commitment pricing

PlexusDx tirzepatide injection mirrors the semaglutide structure with three billing options (prices verified internal records, September 2026):

• Month-to-month: $289/month → $3,468 over 12 months.
• 3-month commitment: $269/month → $3,228 over 12 months.
• 6-month commitment: $249/month → $2,988 over 12 months.

Even PlexusDx's 6-month tirzepatide rate ($249/month) sits well above Fifty410's prepaid tiers. Fifty410's high-dose prepaid plan ($183/month effective) is $66/month cheaper than PlexusDx 6-month tirzepatide, a $792 annual difference. Fifty410's starter tier ($133/month effective) saves $116/month against PlexusDx 6-month tirzepatide, totaling $1,392 over a year.

Side-by-side comparison: all options

Fifty410 prepaid equivalents are our calculation; actual billing is quarterly. PlexusDx commitment rates bill monthly at the stated amount for the term length. All prices verified September 2026.

What the billing models mean in practice

Monthly plans: flexibility and cash-flow control

Fifty410's semaglutide option and PlexusDx month-to-month plans let you pay as you go. If your clinician changes your dose, switches compounds, or pauses therapy, you stop paying immediately. The monthly model also spreads cost evenly: $189 or $199 per billing cycle instead of $399–$549 in a single transaction.

Prepaid and commitment models: lower rates, higher upfront stakes

Fifty410 ships three months of tirzepatide after one payment; you receive the medication before you consume it, which locks in your dose tier for the quarter. If you titrate mid-cycle, the unused vials from the original tier represent sunk cost. PlexusDx 3-month and 6-month plans bill monthly at the discounted rate but require you to stay active for the full term to capture the savings; early cancellation typically forfeits the discount (confirm terms at enrollment).

Dose tiers vs dose-agnostic pricing

Fifty410's tirzepatide catalog separates starter, mid, and high dose into three price points. If your clinician raises your dose from 2.5 mg to 5 mg, your next quarterly payment jumps from $399 to $499. PlexusDx charges one rate across all doses of a given compound: every semaglutide injection ships at $189 month-to-month (or $169/$149 on commitment), whether you take 0.25 mg or 2.4 mg. That structure eliminates mid-treatment price increases but means early-dose patients pay the same as maintenance-dose patients.

Choose Fifty410 prepaid tirzepatide if…

• Your clinician has dialed in a stable tirzepatide dose and you expect to stay on it for at least three months.
• You want the lowest possible effective monthly rate for tirzepatide and can afford the quarterly lump sum.
• You prefer receiving a full quarter's supply upfront rather than monthly shipments.
• You value Fifty410's 4.8-star Trustpilot rating (5,891 reviews, captured September 4, 2026 at www.fifty410.com) as a signal of service consistency.

Choose Fifty410 monthly semaglutide if…

• You want semaglutide with zero upfront commitment and predictable monthly billing.
• You are early in titration and expect dose or compound changes in the next few months.
• You prefer not to lock in multiple months of supply or payment.

Choose PlexusDx if…

• You want month-to-month semaglutide at $189 (vs Fifty410's $199) with no contract.
• You prefer dose-agnostic pricing: one rate regardless of whether you take starter or maintenance doses.
• You are willing to commit to 6 months of semaglutide to capture the $149/month rate, saving $600/year vs Fifty410 semaglutide monthly.
• You value PlexusDx's transparent 4.3-star Trustpilot record (79% five-star, 83% four stars or higher; captured September 9, 2026 at trustpilot.com/review/plexusdx.com) and prefer a provider whose comparison content you are already reading.

For tirzepatide, PlexusDx month-to-month and commitment rates sit above Fifty410's prepaid tiers by $66–$156 per month. If cost is the deciding factor and your dose is stable, Fifty410's prepaid model delivers measurably lower annual spend. If flexibility matters more—especially during titration—PlexusDx month-to-month tirzepatide preserves your ability to adjust without forfeiting prepaid inventory.

Methodology and freshness

We captured Fifty410 pricing from www.fifty410.com/pricing on September 4, 2026 at 13:49:55 UTC. Fifty410's site notes that older help-center documentation may show different tiers; we use only the current pricing page figures. PlexusDx prices reflect internal records verified September 2026. We calculated 12-month totals by multiplying monthly rates by 12 (for recurring plans) and quarterly prepaid amounts by 4 (for Fifty410 tirzepatide). Per-month equivalents for Fifty410's prepaid plans are our arithmetic; the actual billing is one payment per quarter. Review ratings were captured from Trustpilot on the dates noted. We recommend confirming all prices, billing terms, and dose-tier assignments at checkout, as promotional changes or eligibility criteria may alter the figures presented here.

Frequently Asked Questions

Does Fifty410 charge a membership or subscription fee?

No. Fifty410 includes the consult, medication, and shipping in the plan price with no separate membership fee. You pay only if a provider writes a prescription.

Can I switch from Fifty410's monthly semaglutide to prepaid tirzepatide mid-treatment?

Switching compounds requires a new provider consultation and approval. If approved for tirzepatide, you would begin a new prepaid quarterly cycle; your semaglutide subscription would stop. Confirm transition logistics with Fifty410 support before changing.

What happens if my dose changes during a Fifty410 prepaid quarter?

You have already received and paid for three months at the original dose tier. If your clinician raises your dose mid-cycle, the unused lower-dose vials represent sunk cost; your next quarterly payment reflects the new tier. If your dose drops, you cannot retroactively reclaim the difference.

Does PlexusDx penalize early cancellation on 3-month or 6-month plans?

Multi-month commitment terms typically forfeit the discount if you cancel before the term ends. Confirm the exact cancellation policy and any fees during intake or by contacting PlexusDx support before enrolling in a commitment plan.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both Fifty410 and PlexusDx dispense compounded GLP-1 formulations, not brand-name drugs.

Sources

• Fifty410 Pricing Page, www.fifty410.com/pricing – accessed September 4, 2026
• Fifty410 Trustpilot Profile, trustpilot.com/review/fifty410.com – accessed September 4, 2026
• PlexusDx Internal Pricing Records – verified September 2026
• PlexusDx Trustpilot Profile, trustpilot.com/review/plexusdx.com – accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.